Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).
Okamoto K, Hijioka S, Kobayashi N, Imaoka H, Hara K, Takeuchi S, Fujimori N, Sudo K, Horiguchi S, Takada R, Ono T, Terashima T, Shioji K, Kondo S, Furukawa T, Ueno M, Tsumura H, Tobimatsu K, Doi T, Asama H, Kawaguchi S, Kitano Y, Maeda O, Kobayashi S, Arima S, Unno M, Ohno E, Kawata K, Ashida R, Naganuma A, Murohisa G, Yamada R, Satake H, Kodama Y, Yokota I, Okuyama H, Shimizu S, Morizane C, Ueno M, Nagano H, Furuse J; Japan Oncology Network in Hepatobiliary and Pancreas.
Okamoto K, et al. Among authors: hara k.
J Gastroenterol. 2026 Mar 23. doi: 10.1007/s00535-026-02396-3. Online ahead of print.
J Gastroenterol. 2026.
PMID: 41866411